RenovoRx Inc. (RNXT)
NASDAQ · Healthcare
RenovoRx Inc. Income Statement 2024–2025
| Dec 2025 | Dec 2024 | |
|---|---|---|
| Revenues | ||
| Revenue | 1.1M | 43,000 |
| Gross Profit | 796,000 | 43,000 |
| Profitability | ||
| Operating Income | -12.5M | -11.0M |
| EBITDA | -10.5M | -11.0M |
| Net Income | -11.2M | -8.8M |
| Per Share Data | ||
| EPS (diluted) | $-0.32 | $-0.40 |
| Shares Outstanding (dil.) | 35M | 22M |
RenovoRx Inc. Income Statement — FAQ
RenovoRx Inc. (RNXT) income statement over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RNXT's income statement history?
The chart and table above show RenovoRx Inc.'s income statement by year and by quarter, including the growth rate.